Videos and Podcasts
Pharmaxis Presents at MST Access Biotech ‘Hidden Gems’ Forum
Gary Phillips, Chief Executive Officer at Pharmaxis (ASX:PXS) presents at the MST Access Biotech ‘Hidden Gems’ Forum on 20 July 2023.
Watch the presentation here.
MST Financial (“MST”) materials, or any portion thereof, may not be reproduced, sold or redistributed without the prior and written consent of MST. MST Access reports, updates, video interviews and other materials produced by MST Access have generally been engaged and paid by the subject company for ongoing research coverage. Please refer to full disclosures and disclaimers in the company-specific reports.
Pharmaxis Investor Briefing - Clinical Trial Results | 12 July 2023
Pharmaxis Ltd (ASX: PXS) held an online investor briefing by chief executive officer Mr Gary Phillips on July 12 2023.
The event consisted of a short presentation on the final interim analysis of data from patients from the PXS-5505 Phase 2 cancer trial, followed by a Q&A session from attendees.
View the presentation slides here
Pharmaxis Investor Briefing - Clinical Trial Results | 24 May 2023
Pharmaxis Ltd (ASX: PXS) held an online investor briefing by chief executive officer Mr Gary Phillips on May 24 2023.
The event consisted of a short presentation on top line results of an investigator initiated phase 1c clinical trial in established scars, followed by a Q&A session from attendees.
Click here to view the presentation slides.